Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Jerokhimov

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Trauma|April 17, 2002
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot studyMauricio Lynn, Igor Jerokhimov, Dory Jewelewicz, et al.
The American Surgeon|February 14, 2006
Recent trends in the management of combined pancreatoduodenal injuriesPeter P Lopez, Robert Benjamin, Mark Cockburn, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Trauma|April 17, 2002
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot studyMauricio Lynn, Igor Jerokhimov, Dory Jewelewicz, et al.
The American Surgeon|February 14, 2006
Recent trends in the management of combined pancreatoduodenal injuriesPeter P Lopez, Robert Benjamin, Mark Cockburn, et al.
Pageof 1